Navigation Links
SyntheMed Appoints Corinne Mundin as Director, International Market Development
Date:7/18/2008

ISELIN, N.J., July 18 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion, drug delivery products and other surgical implants, announced today the appointment of Ms. Corinne Mundin to the newly-created position of Director, International Market Development. Ms. Mundin, who is based in England, brings more than 20 years of sales, sales management and market development experience in the medical device industry including 10 years in the cardiac surgery product segment. Most recently, she served as Director of International Sales for Novadaq Technologies Inc., a diagnostic equipment company focused on cardiac surgery, and held previous international sales management positions with Chase Medical LLP and Guidant CVS. Ms. Mundin's responsibilities will include enhancing the company's distributor network, establishing corporate relationships with key accounts, and increasing surgeon awareness of the benefits that REPEL-CV(R) Adhesion Barrier, the company's novel anti-adhesion product, can provide in reducing adhesion formation after open heart surgery.

Marc R. Sportsman, SyntheMed's vice president of sales, stated, "We are extremely pleased that Corinne has joined the SyntheMed team and we are confident she will positively impact our sales growth in European and other international markets. Her experience and knowledge of international medical device markets will be critically important as we continue our efforts to establish and improve our distribution channels and increase market penetration."

About Adhesions

Adhesions, or scar tissue, occur after virtually all open-heart surgical procedures, often resulting in the heart becoming attached to the sternum and other surround tissue surfaces. The presence of adhesions represents a prevalent and serious complication in secondary surgical procedures, increasing the length, cost and risk of the
'/>"/>

SOURCE SyntheMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. FDA Panel Recommends Approval of SyntheMeds REPEL-CV(R) Adhesion Barrier for Pediatric Patients
2. SyntheMed to Present at 2007 Lazard Capital Markets Fourth Annual Healthcare Conference
3. SyntheMed, Inc. Adopts Shareholder Rights Plan
4. WorldHeart Appoints David Pellone Chief Financial Officer
5. Novo Nordisk Appoints New Leader of North American Business
6. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
7. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
8. Resonant Medical Appoints New Vice President of Global Sales
9. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
10. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
11. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... TN (PRWEB) June 03, 2015 On ... around the world will gather in their local communities ... Hundreds of cities across the U.S. and abroad will ... to bring attention to the ongoing challenges of cancer ... a cancer diagnosis can be fruitful, rewarding, and inspiring., ...
(Date:6/3/2015)... June 03, 2015 DailyEndorphin is pleased ... programming module. With this highly configurable new offering, ... report on many components of its wellness programming for ... additional charge. , With this new module, annual clients ... challenges, (2) Create participant surveys, (3) Continually report on ...
(Date:6/3/2015)... Foot and Ankle Specialists of ... ( Clarksville Division ) was recently presented with ... Advanced Wound Care (SAWC) and the American Podiatric Medical ... The Conference was held on April 29-May 3, ... San Antonio, TX. , Dr. Casey Friske graduated ...
(Date:6/3/2015)... Tel-Aviv, Israel (PRWEB) June 03, 2015 ... mass-notification, multi-channel solutions, has showcased its new branding by ... , "The new brand identity: the logo ... from red, to green, the tagline – To Know. ... the new path evigilo is charting. A global, borderless ...
(Date:6/2/2015)... Concorde Career Colleges, Inc., announced today the appointment ... manage day-to-day operations for the privately held career college ... to help our Concorde team deliver on our commitment ... part due to reports like Beyond College Rankings from ... and Portland.” , Bell brings 14 years of executive ...
Breaking Medicine News(10 mins):Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 2Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 3Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 4Health News:DailyEndorphin Launches Wellness "Events" Portal 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Receives Award at the Spring 2015 Symposium of Advanced Wound Care Conference 2Health News:Keep calm! evigilos' "sun" will come out tomorrow – to know, to act, in time. 2Health News:Concorde Career Colleges Announces New President and COO 2
... ... well suited for compounding active pharmaceutical ingredients into silicones in a safe and ... ... http://www.nusil.com ), a leading formulator and manufacturer of silicone compounds for the healthcare ...
... technique using tissue from those below-the-waist "love handles" improves ... adequate fat sources elsewhere, a small Johns Hopkins study ... less complicated than other options for surgeons as well, ... the Johns Hopkins University School of Medicine describe the ...
... Ill. They were illiterate farmers, builders and servants, but ... by burying it within their homes. A new study ... more than 1,000 years ago in central Belize begins to ... anthropology professor Lisa J. Lucero, appears in the Journal ...
... around the world will gather in New Orleans, LA, from ... (DDW ), the premiere scientific conference in the fields ... advance of the meeting, please join us for a telebriefing ... leading research and hot topics to be presented at DDW ...
... Brenda ... , ... Brenda Song is an accomplished and well known American actress, singer and model. Brenda decided ... make working on a set more manageable and less complicated. Brenda had successful LASIK ...
... WebLOQ’s LOQMail ... , ... WebLOQ, Inc ., a leader in privacy solutions for secure and compliant business communications, ... Resource Service, Inc. (MARSI) to ensure the security of its client’s patient medical ...
Cached Medicine News:Health News:NuSil Technology Announces Completion of Clean Room Facilities 2Health News:'Love handles' repurposed for breast reconstruction in women without enough belly fat 2Health News:Classic Maya history is embedded in commoners' homes 2Health News:Classic Maya history is embedded in commoners' homes 3Health News:DDW 2010 telebriefing: Preview the latest research and hot topics 2Health News:Brenda Song LASIK video a hit on You Tube 2Health News:Brenda Song LASIK video a hit on You Tube 3Health News:WebLOQ Selected By MARSI to Streamline Medical Audit Reviews From Dispersed Healthcare Community 2Health News:WebLOQ Selected By MARSI to Streamline Medical Audit Reviews From Dispersed Healthcare Community 3Health News:WebLOQ Selected By MARSI to Streamline Medical Audit Reviews From Dispersed Healthcare Community 4
(Date:6/3/2015)... DUBLIN , June 02, 2015 ... the addition of the "Global Neurodegenerative Diseases ... The global neurodegenerative diseases market to grow ... 2014-2019. This report covers the present ... neurodegenerative diseases market for the period 2015-2019. To ...
(Date:6/3/2015)... , June 3, 2015  Armetheon, Inc., a ... for cardiovascular diseases, today announced that Sanjay ... Chief Executive Officer, effective immediately. Dr. Kakkar brings ... high-growth enterprises, with a successful track record in ... health. With expertise that includes the development of ...
(Date:6/3/2015)... , June 3, 2015 TWi ... that it has received final approval from the ... its Abbreviated New Drug Application (ANDA) for Guanfacine ... Pharmaceutical,s Intuniv®.  TWI,s marketing partner, Par Pharmaceuticals, will ... Intuniv® is indicated for the treatment ...
Breaking Medicine Technology:Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs 2Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 2Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 4
... Belgium, March 19, 2012 ADDS A ... SIMPLE ANTIBODY™ PLATFORM   arGEN-X announces today ... the creation of truly differentiated human antibody therapeutics. ... therapeutic antibodies in the human body by engineering of ...
...  Kensey Nash Corporation (NASDAQ: KNSY ) today ... agreement with St. Jude Medical which resolves all disputes ... closure device licenses, as well as other related claims. ... agreed to extend their collagen supply agreement through 2017 ...
Cached Medicine Technology:Argen-X Launches NHance™ Technology to Generate Better Human Antibody Therapies 2Argen-X Launches NHance™ Technology to Generate Better Human Antibody Therapies 3Argen-X Launches NHance™ Technology to Generate Better Human Antibody Therapies 4Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement 2Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement 3Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement 4Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement 5Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement 6
IDS Rapid STR, a microbial identification system....
IDS Rapid NH, a microbial identification system....
Versatrek 240 is versatile as four tests can be performed on one platform such as blood culture, sterile body fluids, mycobacteria and mycobacteria susceptibility testing. This model comes equipped w...
The Riboprinter microbial characterization system provides the speed, accuracy and resolution needed to identify microorganisms and characterize them efficiently and consistently. These determination...
Medicine Products: